Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 49,724 | 50,681 | 40,772 | 32,090 | 18,367 |
| Operating Income | -49,724 | -50,681 | -40,772 | -32,090 | -18,367 |
| Interest Expense | 691 | 543 | 194 | 0 | 0 |
| Other Income | 29 | 37 | 40 | 66 | 49 |
| Pre-tax Income | -50,386 | -51,187 | -40,926 | -32,024 | -18,318 |
| Net Income Continuous | -50,386 | -51,187 | -40,926 | -32,024 | -18,318 |
| Net Income | $-50,386 | $-51,187 | $-40,926 | $-32,024 | $-18,318 |
| EPS Basic Total Ops | -1.33 | -1.35 | -1.09 | -0.87 | 0.33 |
| EPS Basic Continuous Ops | -1.33 | -1.35 | -1.09 | -0.87 | 0.33 |
| EPS Diluted Total Ops | -1.33 | -1.35 | -1.09 | -0.87 | 0.33 |
| EPS Diluted Continuous Ops | -1.33 | -1.35 | -1.09 | -0.87 | 0.33 |
| EBITDA(a) | $-49,515 | $-50,515 | $-40,687 | $-32,058 | $-18,361 |